Structured intelligence coverage

Structured records are temporarily unavailable. The published profile and its source ledger remain accessible.

Identity checks do not refresh the age of governance evidence. Open a record for its source date and review state.

Overview

Business, legal identity, ownership structure and classifications.

What the company does

About

Alpha's canonical identity and public leadership record for Idexx Laboratories.

Sector and industry values retain their source labels. A classification provider, taxonomy version and assignment date are not established unless the cited record states them.

Stable business record

Identity and status

Ownership and listing state

Public listing published

Ownership not asserted

The canonical public record includes at least one active security listing.

Inspect status source
Legal name
IDEXX LABORATORIES INC /DE
Inspect source
Country
US
Inspect source
Jurisdiction
DE
Inspect source
Sector
Healthcare
Inspect source
Official website
https://www.idexx.com
Inspect source

Source-backed public-market identity

Index memberships

Current memberships are attached to a specific security and listing. Announcements, effective dates, and removals remain distinct states; Alpha does not infer membership from company size, exchange, or reputation.

S&P 500S&P Dow Jones Indices · NASDAQ: IDXXcurrentEvidence
Effective
Jan 5, 2017
Removal
Not stated
Announced
Not stated
Last verified
Sep 2, 2026
Verification
inferred
Source
Slickcharts S&P 500 constituent table (public observation, not S&P DJI license)
Nasdaq-100Nasdaq · NASDAQ: IDXXcurrentEvidence
Effective
Sep 1, 2026
Removal
Not stated
Announced
Not stated
Last verified
Sep 2, 2026
Verification
exchange verified
Source
Nasdaq official Nasdaq-100 list-type API

As of Sep 24, 2026. Rights-filtered public evidence only; no redistribution or model training is granted.

Only source-backed memberships with an explicit public redistribution basis are returned.

Relationships and related records

Connections

Explore the roles, education and affiliations published in this record.

Andrew Emerson

Open Andrew Emerson profile →

Andrew Emerson: Executive Vice President and Chief Financial Officer

Start not stated → End not stated

Date not established · source reported

Observed: 2026-09-24

Andrew EmersonAndrew EmersonBruce L. ClaflinBruce L. ClaflinDaniel M. JuniusDaniel M. JuniusIrene Chang BrittIrene Chang BrittJonathan J. MazelskyJonathan J. MazelskyJoseph L. HooleyJoseph L. HooleyKaren PeacockKaren PeacockLawrence D. KingsleyLawrence D. KingsleyMartin SmithMartin SmithMichael G. EricksonMichael G. EricksonMichael J. LaneMichael J. LaneSam SamadSam SamadIdexx Laboratories

Dashed lines mark past roles. Select a connection to see its dates and sources.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · canonical_identityAlpha canonical company public projectionSupports Company identity, Published leadership, Entity status boundary. Reviewed Sep 24, 2026.Open sourceSource 2 · SEC filingIDEXX LABORATORIES INC /DE Form 10-K (filed 2026-02-20)Supports Official website. Reviewed Aug 29, 2026.Open source

Board & Leadership

Board leadership, management, committees and their disclosed responsibilities.

Committee appointments · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

5 public records

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 24, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

11 public records

Disclosure boundary

Governance and independence

Only current, confirmed leadership roles with public evidence are included in the canonical projection.

RecordStatusAuthorityEffective

Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.

Financials & Filings

Reported statements, original filings and proxy disclosures with their reporting periods.

Financial statements · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Filing library · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Proxy & Voting · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Ownership & Markets

Ownership, funding and dated financial information.

Ownership, control and market context · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Ownership disclosures retain their reporting dates and source types. Economic ownership, investment discretion and voting authority are distinct. Activism and settlement-dated short interest are not established by holdings or short-sale volume.

Risk & Assurance

Disclosed coverage, ratings and assurance scope.

Disclosures and oversight · Temporarily unavailable

Structured records for this section are unavailable. This does not establish that no records exist. Published profile sources remain in Evidence & History.

Credit-rating evidence, where published, appears in the Governance and Basis sections with its source and reporting date. Insurance coverage, cyber ratings and assurance reports require their own issuer, scope, date and usage rights. Indemnification does not establish insurance coverage.

Evidence & History

Identifiers, sources and record limitations.

Identifiers

Alpha ID
alpha:company:9afc6ee8-5770-44c9-a6d0-d0f9a1f093db
Record version
public-1

Sources

Sources and published information

Published evidence records

6 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. Alpha canonical company public projection

    canonical identity · Source published: Date unavailable · Retrieved: Sep 24, 2026

    Supports 5 claims
    • Legal Name: IDEXX LABORATORIES INC /DE · Claim reviewed: Sep 24, 2026
    • Entity Status: Public listing published · Claim reviewed: Sep 24, 2026
    • Published Fact: US · Claim reviewed: Sep 24, 2026
    • Published Fact: DE · Claim reviewed: Sep 24, 2026
    • Published Fact: Healthcare · Claim reviewed: Sep 24, 2026

  2. IDEXX LABORATORIES INC /DE Form 10-K (filed 2026-02-20)

    SEC filing · Source published: Date unavailable · Retrieved: Aug 29, 2026

    Supports 2 claims
    • Official Website: https://www.idexx.com · Claim reviewed: Sep 24, 2026
    • Published Fact: https://www.idexx.com · Claim reviewed: Sep 24, 2026

  3. SEC DEF 14A 0000874716-26-000064

    sec def 14a · Source published: Mar 27, 2026 · Retrieved: Sep 14, 2026

    Supports 11 claims
    • Leadership Role: Bruce L. Claflin: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Daniel M. Junius: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Irene Chang Britt: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Jonathan J. Mazelsky: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Lawrence D. Kingsley: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Sam Samad: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Andrew Emerson: Executive Vice President and Chief Financial Officer · Claim reviewed: Sep 24, 2026
    • Leadership Role: Jonathan J. Mazelsky: President and Chief Executive Officer · Claim reviewed: Sep 24, 2026
    • Leadership Role: Martin Smith: Executive Vice President and Chief Technology Officer · Claim reviewed: Sep 24, 2026
    • Leadership Role: Michael J. Lane: Executive Vice President and General Manager, CAG Diagnostics · Claim reviewed: Sep 24, 2026
    • Leadership Role: Tina Hunt: Executive Vice President, Global Strategy and Commercial · Claim reviewed: Sep 24, 2026

  4. IDEXX Laboratories, Inc. DEF 14A 2026-03-27

    sec proxy · Source published: Mar 27, 2026 · Retrieved: May 3, 2026

    Supports 5 claims
    • Leadership Role: Joseph L. Hooley: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Karen Peacock: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Michael G. Erickson: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Sophie V. Vandebroek: Director · Claim reviewed: Sep 24, 2026
    • Leadership Role: Stuart M. Essig: Director · Claim reviewed: Sep 24, 2026

  5. S&P 500

    index provider · Source published: Date unavailable · Retrieved: Sep 2, 2026

    Supports 1 claim
    • Index Membership: S&P 500 (SPX) · Claim reviewed: Sep 24, 2026

  6. Nasdaq-100

    index provider · Source published: Date unavailable · Retrieved: Sep 2, 2026

    Supports 1 claim
    • Index Membership: Nasdaq-100 (NDX) · Claim reviewed: Sep 24, 2026